Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study

We examined the relation between plasma total homocysteine (tHcy), folate, vitamin B12, and episodic memory in elderly community‐dwelling subjects. A population‐based study was conducted in 1992 and 1993, and subjects were re‐investigated after 6 years. Plasma analytes were determined on both occasions. At follow‐up, memory performance, using the Kendrick Object Learning Test, was investigated in 2,189 subjects (age, 65–67 years at baseline). Subjects with memory deficit (test score, <25) had higher tHcy and lower folate at follow‐up compared with those without memory deficit: 12.6 (95% confidence interval [CI], 12.1, 13.1) versus 11.5 (95% CI, 11.3, 11.6) μmol/L (p < 0.001) for tHcy, and 6.7 (95% CI, 6.2, 7.1) versus 7.6 (95% CI, 7.5, 7.8) nmol/L (p < 0.001) for folate. The risk of memory deficit increased according to quintiles of tHcy both at baseline and at follow‐up. A decline in tHcy, or an increase in folate, over a 6‐year period was associated with a higher memory test score; and vice versa. These findings indicate that increased plasma tHcy is an independent risk factor for memory deficit both cross‐sectionally and prospectively, and that a “favorable” change in folate or tHcy concentrations over time is associated with better memory performance. Ann Neurol 2005

[1]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[2]  G. Huston The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[3]  S. Iversen,et al.  Plasma Total Homocysteine and Cognitive Performance in a Volunteer Elderly Population , 2000, Annals of the New York Academy of Sciences.

[4]  L. Parnetti,et al.  Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia , 2001, Mechanisms of Ageing and Development.

[5]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[6]  S. Vollset,et al.  Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study. , 2002, Archives of internal medicine.

[7]  P. Sachdev,et al.  Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals , 2002, Neurology.

[8]  H. Crystal,et al.  Serum Vitamin B12 Levels and Incidence of Dementia in a Healthy Elderly Population: A Report from the Bronx Longitudinal Aging Study , 1994, Journal of the American Geriatrics Society.

[9]  A Hofman,et al.  Homocysteine and cognitive function in the elderly , 2002, Neurology.

[10]  A. Smith,et al.  Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. , 2002, Archives of neurology.

[11]  H. Steinbusch,et al.  Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. , 2003, The journal of nutrition, health & aging.

[12]  P. Rabbitt,et al.  Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. , 1995, Psychology and aging.

[13]  P. Ueland,et al.  Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. , 2001, Clinical chemistry.

[14]  A. Smith,et al.  Low vitamin B-12 status in confirmed Alzheimer’s disease as revealed by serum holotranscobalamin , 2003, Journal of neurology, neurosurgery, and psychiatry.

[15]  I. Rosenberg,et al.  B vitamins, homocysteine, and neurocognitive function in the elderly. , 2000, The American journal of clinical nutrition.

[16]  Ian J Deary,et al.  Homocysteine, B vitamin status, and cognitive function in the elderly. , 2002, The American journal of clinical nutrition.

[17]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[18]  B. Kelleher,et al.  Microbiological assay for vitamin B12 performed in 96-well microtitre plates. , 1991, Journal of clinical pathology.

[19]  C. Patterson,et al.  Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland , 2002, Stroke.

[20]  S. Vollset,et al.  Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. , 2003, Archives of general psychiatry.

[21]  M. Laakso,et al.  Population-Based Dementia Screening Program in Kuopio: The Effect of Education, Age, and Sex on Brief Neuropsychological Tests , 1992, Journal of geriatric psychiatry and neurology.

[22]  P. Ueland,et al.  Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis. , 1998, Clinical chemistry.

[23]  R. Holman,et al.  Underestimation of the Importance of Homocysteine as a Risk Factor for Cardiovascular Disease in Epidemiological Studies , 2001, Journal of cardiovascular risk.

[24]  E. Mariani,et al.  Homocysteine and cognitive function in healthy elderly community dwellers in Italy. , 2003, The American journal of clinical nutrition.

[25]  C. Dufouil,et al.  Homocysteine, white matter hyperintensities, and cognition in healthy elderly people , 2003, Annals of neurology.

[26]  A. Smith,et al.  Total Plasma Homocysteine, Age, Systolic Blood Pressure, and Cognitive Performance in Older People , 2002, Journal of the American Geriatrics Society.

[27]  R. Riezler,et al.  Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. , 1993, The American journal of clinical nutrition.

[28]  S. Vollset,et al.  The Hordaland Homocysteine Studies , 2001, Lipids.

[29]  A. McCaddon,et al.  Total serum homocysteine in senile dementia of Alzheimer type , 1998, International journal of geriatric psychiatry.

[30]  S. Vollset,et al.  The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.

[31]  S. O'broin,et al.  Microbiological assay on microtitre plates of folate in serum and red cells. , 1992, Journal of clinical pathology.

[32]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[33]  I. Graham Homocysteine in Health and Disease , 1999, Annals of Internal Medicine.

[34]  S. Vollset,et al.  Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. , 2004, The American journal of clinical nutrition.

[35]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.

[36]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at −20 °C: Consequences for epidemiologic research , 1995 .

[37]  M. Freedman,et al.  Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[39]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[40]  B. Winblad,et al.  Homocysteine, Apolipoproteine E and Methylenetetrahydrofolate Reductase in Alzheimer’s Disease and Mild Cognitive Impairment , 2003, Dementia and Geriatric Cognitive Disorders.

[41]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[42]  K. Haaland,et al.  Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. , 1997, The American journal of clinical nutrition.

[43]  E Sobel,et al.  Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. , 1993, Archives of neurology.

[44]  A. Smith,et al.  Homocysteine, B vitamins, and cognitive deficit in the elderly. , 2002, The American journal of clinical nutrition.

[45]  P. Laake,et al.  Efficacy of short mental tests in the detection of mental impairment in old age. , 1988, Comprehensive gerontology. Section A, Clinical and laboratory sciences.

[46]  J. Goodwin,et al.  Association between nutritional status and cognitive functioning in a healthy elderly population. , 1983, JAMA.

[47]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[48]  R. Stewart,et al.  Plasma Homocysteine and Cognitive Impairment in an Older British African‐Caribbean Population , 2002, Journal of The American Geriatrics Society.

[49]  P. Lund-Larsen,et al.  The cardiovascular disease study in Norwegian counties. Background and organization. , 1979, Acta medica Scandinavica. Supplementum.

[50]  A. McCaddon,et al.  Homocysteine and Cognitive Decline in Healthy Elderly , 2001, Dementia and Geriatric Cognitive Disorders.

[51]  J. Buckwalter,et al.  Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia. , 1996, Archives of neurology.

[52]  D. Knook,et al.  Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85 , 1999, Journal of neurology, neurosurgery, and psychiatry.

[53]  P. Ueland,et al.  Fully automated fluorescence assay for determining total homocysteine in plasma. , 1989, Clinical chemistry.

[54]  A. Hofman,et al.  Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study , 2002 .

[55]  E. Lesaffre,et al.  Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[56]  C. Gottfries,et al.  Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker , 1998, Dementia and Geriatric Cognitive Disorders.

[57]  A. Lindgren,et al.  Hyperhomocysteinaemia—a common finding in a psychogeriatric population , 1996, European journal of clinical investigation.

[58]  J. Hodges,et al.  The Neuropsychological Differentiation of Patients with Very Mild Alzheimer's Disease and/or Major Depression , 1995, Journal of the American Geriatrics Society.

[59]  Matthijs Oudkerk,et al.  Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study , 2002, Annals of neurology.

[60]  P. Visscher,et al.  Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetetrahydrofolate reductase genes and normal cognitive ageing in humans , 2003, Neuroscience Letters.

[61]  S. A. Areosa,et al.  Folic acid with or without vitamin B12 for cognition and dementia. , 2003, The Cochrane database of systematic reviews.

[62]  W. Markesbery,et al.  Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. , 2000, The American journal of clinical nutrition.

[63]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.

[64]  A. Hofman,et al.  Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. , 1999, American journal of epidemiology.

[65]  P. Ueland,et al.  Homocysteine and other thiols in plasma and urine: automated determination and sample stability. , 1993, Clinical chemistry.

[66]  I. Rosenberg,et al.  Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. , 2001, The American journal of clinical nutrition.

[67]  V. Phongsathorn,et al.  Assessment of kendrick cognitive tests for the elderly , 1991 .

[68]  A. Smith,et al.  Facts and recommendations about total homocysteine determinations: an expert opinion. , 2004, Clinical chemistry.

[69]  Jun-Hyun Yoo,et al.  Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[70]  Kevin M Bradley,et al.  Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.

[71]  J. Qiao,et al.  Homocysteine and Alzheimer's disease. , 1999, Nutrition reviews.

[72]  B. Winblad,et al.  Cobalamin Levels Are Not Reduced in Alzheimer's Disease: Results from a Population‐Based Study , 1994, Journal of the American Geriatrics Society.